- Home
- IINN vs CING Comparison
IINN vs CING Comparison
Compare IINN & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- CING
- Stock Information
- Founded
- IINN 2018
- CING 2012
- Country
- IINN Israel
- CING United States
- Employees
- IINN N/A
- CING N/A
- Industry
- IINN Medical/Dental Instruments
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- CING Health Care
- Exchange
- IINN Nasdaq
- CING Nasdaq
- Market Cap
- IINN 13.7M
- CING 16.2M
- IPO Year
- IINN 2021
- CING 2021
- Fundamental
- Price
- IINN $0.85
- CING $4.10
- Analyst Decision
- IINN Strong Buy
- CING Strong Buy
- Analyst Count
- IINN 1
- CING 4
- Target Price
- IINN $2.00
- CING $30.67
- AVG Volume (30 Days)
- IINN 422.8K
- CING 113.1K
- Earning Date
- IINN 08-14-2025
- CING 08-12-2025
- Dividend Yield
- IINN N/A
- CING N/A
- EPS Growth
- IINN N/A
- CING N/A
- EPS
- IINN N/A
- CING N/A
- Revenue
- IINN N/A
- CING N/A
- Revenue This Year
- IINN N/A
- CING N/A
- Revenue Next Year
- IINN N/A
- CING N/A
- P/E Ratio
- IINN N/A
- CING N/A
- Revenue Growth
- IINN N/A
- CING N/A
- 52 Week Low
- IINN $0.40
- CING $1.80
- 52 Week High
- IINN $1.60
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- IINN 63.38
- CING 47.68
- Support Level
- IINN $0.70
- CING $3.90
- Resistance Level
- IINN $0.77
- CING $4.25
- Average True Range (ATR)
- IINN 0.06
- CING 0.37
- MACD
- IINN 0.01
- CING -0.05
- Stochastic Oscillator
- IINN 75.80
- CING 12.55
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.